CDIO Cardio Diagnostics Holdings Inc

P/E --
Forward P/E --
Price/Sales 366.61
Beta 2.222
Div Yield --
Market Cap --

Company Analysis

Latest News

🟢 Cardio Diagnostics Holdings is trading 6.22% up in after-hours trading amid broader market gains

Cardio Diagnostics Holdings is trading 6.22% up in after-hours trading at $2.05, likely supported by broader positive market sentiment. - It closed August 26,...

🟢 Cardio Diagnostics Holdings is trading 5.6% up in pre-market with no major catalyst identified

Cardio Diagnostics Holdings is trading at $2.02 (+5.60%) in pre-market, with no new company-specific announcement or major catalyst identified for August 26,...

🟢 Cardio Diagnostics Holdings is trading 5.5% up in pre-market as broad risk-on sentiment lifts markets

Cardio Diagnostics Holdings is trading at $2.03, up 5.45% in pre-market, primarily reflecting broader risk-on sentiment. - The price is above the August 24...

🟢 Cardio Diagnostics Holdings is trading 6.49% up today in pre-market

Cardio Diagnostics Holdings is trading at $2.16, up 6.49% after closing at $2.03 on August 21, 2026, with no clear catalyst identified for the pre-market...

🔴 Cardio Diagnostics Holdings is trading 9.5% down today amid possible broader healthcare weakness

Cardio Diagnostics Holdings is trading 9.5% down at $2.00, with broader healthcare weakness a possible factor and no confirmed company-specific catalyst...

🟢 Cardio Diagnostics Holdings is trading 6.77% up in pre-market after August 20 call on commercialization roadmap

Cardio Diagnostics Holdings is trading 6.77% up at $2.36 after its August 20, 2026 investor presentation and call focused on its commercialization roadmap,...

Cardio Diagnostics Touts AI Heart Tests and Medicare Pricing — But Can a $5 Million Company Deliver on Big Promises?

Cardio Diagnostics Touts AI Heart Tests and Medicare Pricing — But Can a $5 Million Company Deliver on Big Promises?

Shares of Cardio Diagnostics Holdings surged 10.6% to $2.20 on August 20 as the micro-cap diagnostics firm filed an investor presentation ahead of a scheduled...

🟢 Cardio Diagnostics Holdings is trading 10.55% up today after filing investor presentation on commercialization strategy

Cardio Diagnostics Holdings is trading 10.55% up at $2.20 after filing an investor presentation emphasizing its commercialization strategy, AI-powered...

🟢 Cardio Diagnostics Holdings is trading 6.53% up today after filing an investor presentation

Cardio Diagnostics Holdings is trading 6.53% up at $2.12 after filing an investor presentation highlighting its commercialization strategy, AI-powered...

Cardio Diagnostics Outlines Commercial Strategy and $854 CMS Reimbursement Rate

Cardio Diagnostics Outlines Commercial Strategy and $854 CMS Reimbursement Rate

Cardio Diagnostics Holdings, Inc. (CDIO) filed an investor presentation detailing its business strategy, market opportunity, and recent operational progress....

🟢 Cardio Diagnostics Holdings is trading 15.4% up in pre-market ahead of August 20, 2026 investor call

Cardio Diagnostics Holdings is trading 15.4% up at $2.30 in pre-market, based on the provided quote, ahead of its August 20, 2026 investor call. - The call...

🟢 Cardio Diagnostics Holdings rises 5.2% — Healthcare Stocks Surge on Strong Earnings Outlook and Investor Rotation

With Healthcare (XLV) up 3.2%, this looks like a sector-led move rather than a company-specific surprise. The healthcare sector experienced a significant...

Cardio Diagnostics Launches In-House Lab, Targeting 40% Gross Margins

Cardio Diagnostics Launches In-House Lab, Targeting 40% Gross Margins

Cardio Diagnostics Holdings, Inc. has opened a high-complexity CLIA-certified laboratory in Iowa City, Iowa. This facility provides the company with end-to-end...

🔴 Cardio Diagnostics Holdings is trading 5.78% down today amid broader market weakness

Cardio Diagnostics Holdings is trading 5.78% down at $1.88 amid broad market weakness. - The S&P 500 is down 0.67%, while the Nasdaq Composite is down...

🟢 Cardio Diagnostics Holdings is trading 10.72% up in pre-market with no clear company-specific catalyst identified

Cardio Diagnostics Holdings is trading at $2.20, 10.72% up in pre-market, with no clear company-specific catalyst identified. - The stock closed at $1.99 on...

🟢 Cardio Diagnostics Holdings is trading 10.05% up in after-hours trading with no clear catalyst identified

Cardio Diagnostics Holdings is trading 10.05% up at $2.19 after closing at $1.99 on August 17, 2026, with no clear catalyst identified for the after-hours...

🟢 Cardio Diagnostics Holdings is trading 6.86% up in pre-market amid Nasdaq Composite's 0.51% pre-market rise

Cardio Diagnostics Holdings is trading at $2.18, up +6.86%, with the move appearing consistent with broader risk-on sentiment. - The Nasdaq Composite was up...

Cardio Diagnostics to Report Earnings Ahead of Major Commercial Update

Cardio Diagnostics to Report Earnings Ahead of Major Commercial Update

Cardio Diagnostics Holdings Inc. will report its quarterly earnings on August 13, 2026. The precision cardiovascular medicine company previously announced on...

🟢 Cardio Diagnostics Holdings is trading 12.45% up in pre-market with no confirmed catalyst identified

Cardio Diagnostics Holdings is trading at $2.26 (+12.45%) in pre-market with no confirmed company-specific catalyst identified for August 14, 2026. - The...

🔴 Cardio Diagnostics Holdings is trading 6.2% down today after two days of gains

Cardio Diagnostics Holdings is trading 6.2% down at $2.04 after no confirmed company-specific catalyst emerged on August 13, 2026. - Shares gained 18.03% on...